The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Indaptus Therapeutics, Inc.(NASDAQ:INDP) 
Indaptus Therapeutics, Inc., a pre-clinical stage biotech company, develops a patented anti-cancer and antiviral immunotherapy. It engages in developing a pre-clinical pipeline of therapeutic candidates intended to elicit anti-tumor and anti-viral responses, as well as cure diseases. The company's l...
Share this website to your friends
Indaptus Therapeutics . Days Payable Outstanding ttm (DPO)
Indaptus Therapeutics . Op Cashflow Per Share ttm
Indaptus Therapeutics . Free Cashflow Per Share ttm
Indaptus Therapeutics . Cash Per Share ttm
Indaptus Therapeutics . (GAAP) P/E ratio ttm
Indaptus Therapeutics . P/B ratio ttm
No extra charts and metrics for this ticker.